Clinical Oncology Next Generation Sequencing Ngs Market Size And Share

  • Report Code : TIPRE00007163
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

臨床腫瘍学における次世代シーケンシング（NGS）市場シェア分析と機会 2025-2031

Buy Now

Clinical Oncology Next Generation Sequencing (NGS) Market Report Clinical Oncology Next Generation Sequencing (NGS) Market Scope and Analysis Clinical Oncology Next Generation Sequencing (NGS) Market Size and Share

Clinical Oncology Next Generation Sequencing (NGS) Market Report Analysis

Clinical Oncology Next Generation Sequencing (NGS) Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Agilent Technologies, Inc.
  • Caris Life Sciences
  • F. Hoffmann-La Roche Ltd
  • FOUNDATION MEDICINE, INC.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc
  • QIAGEN

Regional Overview

  • 北米
  • ヨーロッパ
  • アジア太平洋
  • 中南米
  • 中東およびアフリカ

Market Segmentation

By テクノロジー（全エクソーム配列解析,全ゲノム配列解析,標的配列解析および再配列解析）
By ワークフロー
  • NGS データ解析
  • NGS プレシーケンス
  • NGS シーケンス
By アプリケーション（コンパニオン診断,スクリーニング,その他のアプリケーション）
By エンドユーザー（病院,診療所,研究所）